Cargando…
Model structures of inactive and peptide agonist bound C5aR: Insights into agonist binding, selectivity and activation
C5a receptor (C5aR) is one of the major chemoattractant receptors of the druggable proteome that binds C5a, the proinflammatory polypeptide of complement cascade, triggering inflammation and SEPSIS. Here, we report the model structures of C5aR in both inactive and peptide agonist (YSFKPMPLaR; a=D-Al...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668562/ https://www.ncbi.nlm.nih.gov/pubmed/29124137 http://dx.doi.org/10.1016/j.bbrep.2015.03.002 |
_version_ | 1783275699463782400 |
---|---|
author | Rana, Soumendra Sahoo, Amita Rani |
author_facet | Rana, Soumendra Sahoo, Amita Rani |
author_sort | Rana, Soumendra |
collection | PubMed |
description | C5a receptor (C5aR) is one of the major chemoattractant receptors of the druggable proteome that binds C5a, the proinflammatory polypeptide of complement cascade, triggering inflammation and SEPSIS. Here, we report the model structures of C5aR in both inactive and peptide agonist (YSFKPMPLaR; a=D-Ala) bound meta-active state. Assembled in CYANA and evolved over molecular dynamics (MD) in POPC bilayer, the inactive C5aR demonstrates a topologically unique compact heptahelical bundle topology harboring a β-hairpin in extracellular loop 2 (ECL2), derived from the atomistic folding simulations. The peptide agonist bound meta-active C5aR deciphers the “site2” at an atomistic resolution in the extracellular surface (ECS), in contrast to the previously hypothesized inter-helical crevice. With estimated Ki≈2.75 μM, the meta-active C5aR excellently rationalizes the IC(50) (0.1–13 μM) and EC(50) (0.01–6 μM) values, displayed by the peptide agonist in several signaling studies. Moreover, with Ki≈5.3×10(5) μM, the “site2” also illustrates selectivity, by discriminating the stereochemical mutant peptide (YSFkPMPLaR; k=D-Lys), known to be inert toward C5aR, up to 1 mM concentration. Topologically juxtaposed between the structures of rhodopsin and CXCR1, the C5aR models also display excellent structural correlations with the other G-protein coupled receptors (GPCRs). The models elaborated in the current study unravel many important structural insights previously not known for regulating the agonist binding and activation mechanism of C5aR. |
format | Online Article Text |
id | pubmed-5668562 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-56685622017-11-09 Model structures of inactive and peptide agonist bound C5aR: Insights into agonist binding, selectivity and activation Rana, Soumendra Sahoo, Amita Rani Biochem Biophys Rep Research Article C5a receptor (C5aR) is one of the major chemoattractant receptors of the druggable proteome that binds C5a, the proinflammatory polypeptide of complement cascade, triggering inflammation and SEPSIS. Here, we report the model structures of C5aR in both inactive and peptide agonist (YSFKPMPLaR; a=D-Ala) bound meta-active state. Assembled in CYANA and evolved over molecular dynamics (MD) in POPC bilayer, the inactive C5aR demonstrates a topologically unique compact heptahelical bundle topology harboring a β-hairpin in extracellular loop 2 (ECL2), derived from the atomistic folding simulations. The peptide agonist bound meta-active C5aR deciphers the “site2” at an atomistic resolution in the extracellular surface (ECS), in contrast to the previously hypothesized inter-helical crevice. With estimated Ki≈2.75 μM, the meta-active C5aR excellently rationalizes the IC(50) (0.1–13 μM) and EC(50) (0.01–6 μM) values, displayed by the peptide agonist in several signaling studies. Moreover, with Ki≈5.3×10(5) μM, the “site2” also illustrates selectivity, by discriminating the stereochemical mutant peptide (YSFkPMPLaR; k=D-Lys), known to be inert toward C5aR, up to 1 mM concentration. Topologically juxtaposed between the structures of rhodopsin and CXCR1, the C5aR models also display excellent structural correlations with the other G-protein coupled receptors (GPCRs). The models elaborated in the current study unravel many important structural insights previously not known for regulating the agonist binding and activation mechanism of C5aR. Elsevier 2015-03-24 /pmc/articles/PMC5668562/ /pubmed/29124137 http://dx.doi.org/10.1016/j.bbrep.2015.03.002 Text en © 2015 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Article Rana, Soumendra Sahoo, Amita Rani Model structures of inactive and peptide agonist bound C5aR: Insights into agonist binding, selectivity and activation |
title | Model structures of inactive and peptide agonist bound C5aR: Insights into agonist binding, selectivity and activation |
title_full | Model structures of inactive and peptide agonist bound C5aR: Insights into agonist binding, selectivity and activation |
title_fullStr | Model structures of inactive and peptide agonist bound C5aR: Insights into agonist binding, selectivity and activation |
title_full_unstemmed | Model structures of inactive and peptide agonist bound C5aR: Insights into agonist binding, selectivity and activation |
title_short | Model structures of inactive and peptide agonist bound C5aR: Insights into agonist binding, selectivity and activation |
title_sort | model structures of inactive and peptide agonist bound c5ar: insights into agonist binding, selectivity and activation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668562/ https://www.ncbi.nlm.nih.gov/pubmed/29124137 http://dx.doi.org/10.1016/j.bbrep.2015.03.002 |
work_keys_str_mv | AT ranasoumendra modelstructuresofinactiveandpeptideagonistboundc5arinsightsintoagonistbindingselectivityandactivation AT sahooamitarani modelstructuresofinactiveandpeptideagonistboundc5arinsightsintoagonistbindingselectivityandactivation |